The healthcare sector comprises more than 20 different industries, from the mega cap pharmaceutical behemoths to the nimble, microcap biotech companies, with a variety of medical device companies and healthcare services industries in between.
Despite scientific advances, there remain significant unmet medical needs today in areas such as Alzheimer’s disease, cancer and pain. Research and development is the lifeblood of the healthcare sector and both companies and academia are constantly striving to improve our understanding in these unmet areas. While the big pharma industry is struggling with the loss of exclusivity on a raft of products, there are plenty of examples of innovative companies in other industries that are experiencing revenue growth. One example is Alexion, a biotech company whose drug Soliris, approved in 2...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
